Association of serum prostate-specific antigen (PSA) level and circulating tumor cell-based PSA mRNA in prostate cancer

BACKGROUND: Prostate-specific antigen (PSA) is used for diagnosing prostate cancer, but does not reflect the characteristics of prostate cancer cells to allow assessment of cancer progression. PSA mRNA and circulating tumor cells (CTCs) could be potential biomarkers. However, the relationship betwee...

Descripción completa

Detalles Bibliográficos
Autores principales: Cho, Hyungseok, Oh, Cheol Kyu, Cha, Jiwon, Chung, Jae Il, Byun, Seok-Soo, Hong, Sung Kyu, Chung, Jae-Seung, Han, Ki-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asian Pacific Prostate Society 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844604/
https://www.ncbi.nlm.nih.gov/pubmed/35229001
http://dx.doi.org/10.1016/j.prnil.2022.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8844604/
https://www.ncbi.nlm.nih.gov/pubmed/35229001
http://dx.doi.org/10.1016/j.prnil.2022.01.002

Ejemplares similares